ReviewAnimals : an open access journal from MDPI2026
Near-Infrared Imaging in Small Animal Surgical Oncology: Current Applications and Future Directions.
Review in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of near-infrared (NIR) fluorescence imaging has become increasingly widespread in the intraoperative management of human cancer patients, with diverse applications that enhance the visualization of tumors, metastatic lesions, draining lymph nodes, and critical anatomy. In recent years, the adoption of NIR imaging in small animal surgical oncology has grown, with reported applications including nonselective and selective tumor imaging as well as sentinel lymph node (SLN) mapping for staging and surgical guidance. Despite these advances, clinical use in veterinary patients remains in its early stages, and further work is needed to define indications, optimize protocols, and determine its impact on outcomes. This review summarizes the current applications of NIR imaging in companion animal oncologic surgery, including techniques for dye administration, imaging agents, and reported clinical uses across tumor types. Key limitations are discussed, including limited tissue penetration, lack of tumor specificity with commonly used agents such as indocyanine green, variability in protocols, and limited data in certain species. Emerging technologies, including targeted fluorescent agents and advanced imaging approaches, are also highlighted. Overall, NIR imaging represents a promising adjunct in small animal surgical oncology, though further study and standardization are needed to support broader clinical integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.